These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1244083)

  • 21. A comparison of fluorescent and nonfluorescent light sources for phototherapy.
    Warshaw JB; Gagliardi J; Patel A
    Pediatrics; 1980 Apr; 65(4):795-8. PubMed ID: 7367087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolites and enzyme activities involved in tryptophan metabolism in two different strains of mouse.
    Costa C; De Antoni A; Baccichetti F; Biasiolo M; Allegri G
    Ital J Biochem; 1984; 33(5):319-24. PubMed ID: 6511306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of urinary excretion of 3-hydroxykynurenine and 3-hydroxyanthranilic acid after tryptophan loading in man.
    Hansson O
    Acta Soc Med Ups; 1968; 73(1):11-8. PubMed ID: 5677553
    [No Abstract]   [Full Text] [Related]  

  • 24. The modification of proteins by 3-hydroxykynurenine.
    Stutchbury GM; Truscott RJ
    Exp Eye Res; 1993 Aug; 57(2):149-55. PubMed ID: 8405181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.
    de Vries LV; Minović I; Franssen CFM; van Faassen M; Sanders JS; Berger SP; Navis G; Kema IP; Bakker SJL
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F475-F486. PubMed ID: 28490533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary tryptophan metabolites: assay of free and acid hydrolyzable conjugates of 3-hydroxykynurenine and 3-hydroxyanthranilic acid.
    Yeh JK; Brown RR
    Biochem Med; 1975 Sep; 14(1):12-23. PubMed ID: 1212237
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tryptophan and its metabolites in renal allograft recipients].
    Myśliwiec P; Myśliwiec H; Pawlak D; Dadan J; Buczko W; Pawlak K
    Przegl Lek; 2009; 66(3):115-8. PubMed ID: 19689033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on tryptophan metabolism in Danish bladder cancer patients.
    Wolf H; Brown RR; Nyholm K
    Acta Vitaminol Enzymol; 1975; 29(1-6):117-22. PubMed ID: 1244080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune competence assessment in hyperbilirubinemic newborns before and after phototherapy.
    Rubaltelli FF; Piovesan AL; Semenzato G; Barbato A; Ongaro G
    Helv Paediatr Acta; 1977 Jul; 32(2):129-33. PubMed ID: 311357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of 4-desoxypyridoxine on the initial excretion rates of 3-hydroxykynurenine and 3-hydroxyanthranilic acid after tryptophan loading.
    Hansson O
    Acta Soc Med Ups; 1968; 73(1):19-34. PubMed ID: 5677554
    [No Abstract]   [Full Text] [Related]  

  • 31. The urinary ratio of 3-hydroxykynurenine/3-hydroxyanthranilic acid is an index to predicting the adverse effects of D-tryptophan in rats.
    Shibata K; Ohno T; Sano M; Fukuwatari T
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):261-8. PubMed ID: 25297615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory role of tryptophan degradation pathway in HLA-G expression by human monocyte-derived dendritic cells.
    López AS; Alegre E; LeMaoult J; Carosella E; González A
    Mol Immunol; 2006 Jul; 43(14):2151-60. PubMed ID: 16490253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of increased light as routine prophylaxis for hyperbilirubinemia of the low-birthweight infant.
    Gellis SS
    Birth Defects Orig Artic Ser; 1970 Jun; 6(2):90-2. PubMed ID: 5522338
    [No Abstract]   [Full Text] [Related]  

  • 34. Determination of urinary tryptophan, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in neonatal hyperbilirubinaemic infants using reversed-phase high-performance liquid chromatography with fluorescence detection.
    Iwatani A; Nakamura H
    J Chromatogr; 1984 Jul; 309(1):145-50. PubMed ID: 6207193
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of development of bronze baby syndrome in neonates treated with phototherapy.
    Onishi S; Itoh S; Isobe K; Togari H; Kitoh H; Nishimura Y
    Pediatrics; 1982 Mar; 69(3):273-6. PubMed ID: 7063284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of mutation-induced excess brain concentration of intermediates of the kynurenine pathway of tryptophan metabolism on stress resistance and courtship behavior and communicative sound production in male Drosophila melanogaster].
    Popov AV; Peresleni AI; Savvateeva-Popova EV; Riederer P
    Genetika; 2008 Sep; 44(9):1216-26. PubMed ID: 18846819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The course of hyperbilirubinemia in the very low birth weight infant treated with phenobarbital.
    Anwar M; Valdivieso J; Hiatt IM; Hegyi T
    J Perinatol; 1987; 7(2):145-8. PubMed ID: 3505611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal function in full-term neonates with hyperbilirubinemia.
    Haimi-Cohen Y; Merlob P; Davidovitz M; Eisenstein B
    J Perinatol; 1997; 17(3):225-7. PubMed ID: 9210080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of phototherapy on nutrients utilization in newborn infants with jaundice.
    Tontisirin K; Tejavej A; Siripoonya P; Satayasai V; Gjernsritrakul C; Valaiphatchara U
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():177-82. PubMed ID: 2732639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference of some tryptophan metabolites in the formation of melanin in vitro.
    Soddu G; Sanjust E; Murgia S; Rescigno A
    Pigment Cell Res; 2004 Apr; 17(2):135-41. PubMed ID: 15016302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.